Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation
Clinical trial NCT04366232 · TERMINATED
Trial details
- NCT number
- NCT04366232
- Sponsor
- Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2020-10-02
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.